首页> 外文期刊>International Journal of Pharmaceutics >Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes.
【24h】

Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes.

机译:有效递送西多福韦的新型聚合物/脂质混合系统(PLH):聚合物颗粒和脂质体的制备,表征和体外比较研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cidofovir is an antiviral drug active as antitumoral agent a high doses against the Primary Effusion Lymphoma, a herpesvirus HHV8-associated B-cell lymphoma. A novel polymeric/lipidic hybrid system, consisting in a specific combination of biocompatible materials, capable to build a crossbred between polymeric particles and liposomes were prepared and used to stabilize and deliver the drug, unsuccessfully formulated into several types of carriers. This innovative cidofovir-delivering system has structurally been characterized in comparison to multilamellar liposomes and polymeric particles, and then tested for antitumoral efficacy against tumor cells (BCBL-1 cell line). The results demonstrated the improving of drug stability and encapsulation efficiency and suggested that polymeric/lipidic hybrid system could be promising to improve the antitumoral effect of cidofovir even at lower doses.
机译:西多福韦是一种抗病毒药,具有高剂量作为抗肿瘤药,可有效对抗疱疹病毒HHV8相关的B细胞淋巴瘤原发性淋巴瘤。制备了一种新颖的聚合物/脂质混合体系,该体系由生物相容性材料的特定组合组成,能够在聚合物颗粒和脂质体之间建立杂交体,并用于稳定和递送药物,未成功配制成几种类型的载体。与多层脂质体和聚合物颗粒相比,这种创新的西多福韦递送系统已在结构上得到了表征,然后测试了其对肿瘤细胞(BCBL-1细胞系)的抗肿瘤功效。结果证明了药物稳定性和包封效率的提高,并且表明聚合物/脂质混合系统即使在较低剂量下也有望改善西多福韦的抗肿瘤作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号